Latest News & Views in Diabetes Technology

If you've been hearing whispers about a new kind of sensor on the horizon, you're not imagining things. The FreeStyle Libre brand is preparing to launch a sensor that does something no continuous sensor has done before: track two different analytes at once — glucose and ketones.

Key takeaways

• It's the first continuous sensor to monitor two analytes for diabetes care
• FDA-cleared August 25, 2026
• Expected to be available in the US by the end of 2026
• Approved for ages 2 and up

Introducing the New Continuous Glucose + Ketone Sensor

Abbott Diabetes Care — the makers of the FreeStyle Libre continuous glucose monitoring systems — is preparing to launch its new Libre DUO 10 Day System, designed for people with diabetes ages 2 years and older.

This single sensor does double duty:

• Tracks glucose minute-by-minute, just like existing Libre sensors
• Monitors ketones in the background at the same time
• Triggers an Urgent High Ketones alarm when levels climb above 3.0 mmol/L

The sensor measures β-hydroxybutyrate (BHB) - the same analyte hospital laboratories measure in the blood - bringing that same clinical-grade marker to a wearable, continuous format for the first time.

Leveraging the Libre Ecosystem

The DUO sensor is designed to leverage the same reporting and data-sharing ecosystem that Libre users are already familiar with:

AID System Integration Partners: What's Available When

Automated insulin delivery (AID) compatibility is rolling out in phases:

Expected by end of 2026:

• Beta Bionics: iLet
• Sequel: twiist

Expected in 2027:

• Tandem: t:slim X2 and Mobi
• Insulet: Omnipod
• Partnership with MiniMed

Watch This Space

Continuous ketone monitoring is a new frontier in diabetes care. As more details emerge on availability, coverage, and clinical guidance, we'll be covering it here. Check back soon for updates as the Libre DUO 10 Day System makes its way to patients and providers across the US.